Menu
CoinPost
CPT Developers
Topics
Market
Events
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.
Moleculin completes patient dosing in Part A of MIRACLE trial - CoinPost Terminal
Back
Moleculin completes patient dosing in Part A of MIRACLE trial
Oct 30, 2026 12:40 (2h ago)
Verifying
AI Summary
Moleculin completed patient dosing in Part A of the MIRACLE trial.
Q1 2027 is the target timeframe for a comprehensive data readout.
The MIRACLE study is described as pivotal.
Related Topics
Media
1